Overcoming the Next Cannabis Vaporizer Crisis

Equipment manufacturers work to prevent additional injuries

Written byPolyScience
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

As the cannabis industry turns a corner into legality, a wellspring of evidence shows that vaping — initially considered a healthy method for consuming cannabis — might present more danger to consumers than once thought. In 2019, contaminated vaporizer pens from black-market producers sickened thousands of users and killed several dozen, and research published in the American Journal of Preventive Medicine reported that the tobacco vaporizers on the market today are just as damaging as cigarettes. Consumers are left questioning whether they should vape at all. Now, cannabis industry experts predict a second vaporizer crisis with injuries that will manifest differently than those of the first.

In the first vaporizer crisis, which began in August, doctors reported thousands of cases of what the Center for Disease Control came to call “e-cigarette, or vaping, product use-associated lung injury” (EVALI). A thickening agent in the vaporizer oils — vitamin E acetate — ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies